内容摘要：When asked if he still wanted to be with the Stars, and if he felt good about the chances of that happening, he answered yes to both.

When asked if he still wanted to be with the Stars, and if he felt good about the chances of that happening, he answered yes to both.

The FDA’s announcement appears to usurp that advisory panel’s job, Offit said. He added that CDC studies have made clear that booster doses do offer protection against mild to moderate illness for four to six months after the shot even in healthy people.The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.

WASHINGTON (AP) — Democrats and Republicans alike raised concerns on Wednesday about deep staffing cuts, funding freezes and far-reaching policy changes overseen byA bipartisan group of lawmakers questioned Kennedy’s approach to the job, some saying that he has jeopardized vaccine uptake, cancer research and dental health in just a few short months.In combative and at times highly personal rejoinders, Kennedy defended the Trump

to reshape the sprawling, $1.7 trillion-a-year agency, saying it would deliver a more efficient department focused on promoting healthier lifestyles among Americans.Sen. Bill Cassidy, R-La., votes aye at the final moment as the Senate Finance Committee holds a roll call vote to approve the nomination of Robert F. Kennedy Jr. to lead the Health and Human Services Department, at the Capitol in Washington, Feb. 4, 2025. (AP Photo/J. Scott Applewhite, File)

Sen. Bill Cassidy, R-La., votes aye at the final moment as the Senate Finance Committee holds a roll call vote to approve the nomination of Robert F. Kennedy Jr. to lead the Health and Human Services Department, at the Capitol in Washington, Feb. 4, 2025. (AP Photo/J. Scott Applewhite, File)

“There’s so much chaos and disorganization in this department,” Kennedy said on Wednesday during the Senate hearing. “What we’re saying is let’s organize in a way that we can quickly adopt and deploy all these opportunities we have to really deliver high-quality health care to the American people.”Last week, Moderna pushed its target date for the vaccine’s approval to 2026 after the Food and Drug Administration requested a more direct measure: how much the shot lowered the risk of disease.

“I agree in this case with FDA that efficacy data are important to see,” Poland said.Health Secretary Robert F. Kennedy Jr. has cast doubt on the safety of mRNA vaccines, but Moderna President Stephen Hoge told investors in an earnings call last week that talks with the FDA were productive and “business as usual.”

the FDA was asking the company to run a new clinical trial of its protein-based COVID-19 vaccine after the agency grants full approval, sowing uncertainty about other vaccine updates.The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.